{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantity:
Thymosin alpha-1 (Ta1) is a 28-amino-acid peptide naturally produced by the thymus gland and derived from a larger precursor protein called prothymosin alpha. It acts as an immune modulator rather than a simple immune booster, helping coordinate both innate and adaptive immune responses.
Key Functions & Mechanisms
• Immune Regulation: Binds to toll-like receptors (such as TLR-2, TLR-3, TLR-4, and TLR-9) on dendritic cells to stimulate T-cell differentiation, maturation, and function.
• Cytokine Balance: Promotes Th1-mediated responses and helps regulate inflammatory signals, which can reduce the severity of excessive inflammatory reactions.
Clinical & Medical Status
• Global Approval: Its synthetic version, thymalfasin (marketed as Zadaxin), is approved in more than 35 countries to treat chronic viral hepatitis (B and C) and to support immune function in specific conditions.
• Research Context: It has been studied in clinical and research settings as an adjuvant for cancer therapies, vaccine enhancement, and immune-deficiency support, though safety, quality, and efficacy vary widely outside of regulated pharmaceutical manufacturing